Influence of deoxynivalenol on NF-κB activation and IL-8 secretion in human intestinal Caco-2 cells

被引:54
作者
De Walle, Jacqueline Van [1 ]
Romier, Beatrice [1 ]
Larondelle, Yvan [1 ]
Schneider, Yves-Jacques [1 ]
机构
[1] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium
关键词
deoxynivalenol; intestinal inflammation; NF-kappa B/I kappa B pathway; II-8; secretion; Caco-2; cells;
D O I
10.1016/j.toxlet.2008.01.018
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Deoxynivalenol (DON) is the most prevalent trichothecene mycotoxin in crops in Europe and North America. In human intestinal Caco-2 cells, DON activates the mitogen-activated protein kinases (MAPKs). We hypothesized a link between DON ingestion and intestinal inflammation, and used Caco-2 cells to assess the effects of DON, at plausible intestinal concentrations (250- 10,000 ng/ml), on inflammatory mediators acting downstream the MAPKs cascade i.e. activation of nuclear factor-kappa B (NF-kappa B) and interleukin-8 (IL-8) secretion. In addition, Caco-2 cells were co-exposed to pro-inflammatory stimuli in order to mimic an inflamed intestinal epithelium. Dose-dependent increases in NF-kappa B activity and IL-8 secretion were observed, reaching 1.4- and 7.6-fold, respectively using DON at 10 mu g/ml. Phosphorylation of inhibitor-kappa B (I kappa B) increased (1.6-fold) at DON levels <0.5 mu g/ml. Exposure of Caco-2 cells to pro-inflammatory agents, i.e. 25 ng/ml interleukin-1 beta, 100 ng/ml tumor necrosis factor-alpha or 10 mu g/ml lipopolysaccharides, activated NF-kappa B and increased IL-8 secretion. Synergistic interactions between these stimuli and DON were observed. These data show that DON induces NF-kappa B activation and IL-8 secretion dose-dependently in Caco-2 cells, and this effect was accentuated upon pro-inflammatory stimulation, suggesting DON exposure could cause or exacerbate intestinal inflammation. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 66 条
[1]  
Abramoff MD., 2004, Biophot. Int., V11, P36
[2]   iNOS-mediated nitric oxide production and its regulation [J].
Aktan, F .
LIFE SCIENCES, 2004, 75 (06) :639-653
[3]   EFFECTS OF VOMITOXIN (DEOXYNIVALENOL) AND CYCLOHEXIMIDE ON IL-2, IL-4, IL-5 AND IL-6 SECRETION AND MESSENGER-RNA LEVELS IN MURINE CD4(+) CELLS [J].
AZCONAOLIVERA, JI ;
OUYANG, YL ;
WARNER, RL ;
LINZ, JE ;
PESTKA, JJ .
FOOD AND CHEMICAL TOXICOLOGY, 1995, 33 (06) :433-&
[4]   Genotoxicity assessment of deoxynivalenol in the Caco-2 cell line model using the Comet assay [J].
Bony, Sylvie ;
Carcelen, Monique ;
Olivier, Laurence ;
Devaux, Alain .
TOXICOLOGY LETTERS, 2006, 166 (01) :67-76
[5]   Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance [J].
Caradonna, L ;
Amati, L ;
Magrone, T ;
Pellegrino, NM ;
Jirillo, E ;
Caccavo, D .
JOURNAL OF ENDOTOXIN RESEARCH, 2000, 6 (03) :205-214
[6]   ELEVATED GENE-EXPRESSION AND PRODUCTION OF INTERLEUKIN-2, INTERLEUKIN-4, INTERLEUKIN-5, AND INTERLEUKIN-6 DURING EXPOSURE TO VOMITOXIN (DEOXYNIVALENOL) AND CYCLOHEXIMIDE IN THE EL-4 THYMOMA [J].
DONG, WM ;
AZCONAOLIVERA, JI ;
BROOKS, KH ;
LINZ, JE ;
PESTKA, JJ .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1994, 127 (02) :282-290
[7]  
*EC, 2003, COLL OCC DAT FUS TOX, P1
[8]  
Fornelli F, 2004, IN VITRO CELL DEV-AN, V40, P166, DOI 10.1290/1543-706X(2004)40<166:CIBNDA>2.0.CO
[9]  
2
[10]   Effect of various doses of deoxynivalenol on liver xenoblotic metabolizing enzymes in mice [J].
Gouze, ME ;
Laffitte, J ;
Rouimi, P ;
Loiseau, N ;
Oswald, IP ;
Galtier, P .
FOOD AND CHEMICAL TOXICOLOGY, 2006, 44 (04) :476-483